Patents by Inventor Kim Orth

Kim Orth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulating bacterial MAM polypeptides in pathogenic disease
    Patent number: 9529005
    Abstract: The present invention relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a MAM polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: December 27, 2016
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Kim Orth, Hyeilin Ham, Anne-Marie Krachler
  • MODULATING BACTERIAL MAM POLYPEPTIDES IN PATHOGENIC DISEASE
    Publication number: 20160169921
    Abstract: The present invention relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a MAM polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
    Type: Application
    Filed: September 22, 2015
    Publication date: June 16, 2016
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Kim ORTH, Hyeilin HAM, Anne-Marie KRACHLER
  • Modulating bacterial MAM polypeptides in pathogenic disease
    Patent number: 9140698
    Abstract: The disclosure relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a multivalent adhesion molecule (MAM) polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: September 22, 2015
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Kim Orth, Hyeilin Ham, Anne-Marie Krachler
  • MODULATING BACTERIAL MAM POLYPEPTIDES IN PATHOGENIC DISEASE
    Publication number: 20140093477
    Abstract: The disclosure relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a multivalent adhesion molecule (MAM) polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.
    Type: Application
    Filed: March 30, 2012
    Publication date: April 3, 2014
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Kim Orth, Hyeilin Ham, Anne-Marie Krachler
  • O-ACETYLTRANFERASES
    Publication number: 20070264668
    Abstract: A post-translational modification of a predetermined protein expressed by a cell is detected by specifically detecting an O-acetylation of a serine, threonine or tyrosine residue of the protein as an indication of the posttranslational modification. The detection may employ antibodies that specifically bind an O-acetylated protein expressed by the cell, wherein the specific binding is dependent on the presence of an O-acetylated serine, threonine or tyrosine residue in the protein.
    Type: Application
    Filed: May 11, 2006
    Publication date: November 15, 2007
    Inventors: Kim Orth, Sohini Mukherjee
  • O-acetyltranferases
    Patent number: 7291476
    Abstract: A post-translational modification of a predetermined protein expressed by a cell is detected by specifically detecting an O-acetylation of a serine, threonine or tyrosine residue of the protein as an indication of the post-translational modification. The detection may employ antibodies that specifically bind an O-acetylated protein expressed by the cell, wherein the specific binding is dependent on the presence of an O-acetylated serine, threonine or tyrosine residue in the protein.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: November 6, 2007
    Assignee: Board of Regents, The University of Texas System
    Inventors: Kim Orth, Sohini Mukherjee